Responsiveness of epigenetic aging biomarkers to longevity interventions in humans
Key claim: Nature reports that epigenetic aging biomarkers are responsive to longevity interventions in humans.
Abstract
News coverage by Nature: “Responsiveness of epigenetic aging biomarkers to longevity interventions in humans”. Headline and link only — this finding reports press coverage of a government action, not the primary record.
Why this matters
Responsiveness of epigenetic clocks to interventions is the crux of whether these tools are useful for trials and consumer products, and Nature-tier coverage amplifies that framing far beyond what a press summary can substantiate. Every claim of this shape reruns the recurring trap in this area — treating clock movement as proof of de-aging — without addressing which clock, which tissue, and which outcome the movement predicts.